收藏切换
Clinical research progress of the antifungal drug ibrexafungerp
收藏切换
Junyi WANG, Haodong CHEN, Jiawei TANG, Songbai YANG, Shaoxin CHEN*
World Clinical Drug | 2025, 46(9) : 972 - 977
Less
收藏切换
World Clinical Drug | 2025, 46(9): 972-977
• Review •
Clinical research progress of the antifungal drug ibrexafungerp
Full
Junyi WANG, Haodong CHEN, Jiawei TANG, Songbai YANG, Shaoxin CHEN*
Affiliations
  • China state Institute of Pharmaceutical Industry, Shanghai Institute of Pharmaceutical Industry, National Key Laboratory of Lead Druggability Research, Shanghai 201203, China
Published: 2025-09-10 doi: 10.13683/j.wph.2025.09.016
Outline
收藏切换

With the increase of invasive fungal infections, the use of antifungal drug has become more frequently, and the emergence of fungal resistance has become an inevitable problem. Given the limited availability of existing antifungal drugs and their severe side effects, the United States Food and Drug Administration has approved a new antifungal drug, ibrexafungerp, which is a semi-synthetic chemical derivative of the natural product enfumafungin. It has broad-spectrum antibacterial activity, demonstrates strong antibacterial activity against Candida and Aspergillus, including those echinocandins- and azoles-resistant strains. It's currently used in the clinical treatment of vulvovaginal candidiasis. Ibrexafungerp has good oral bioavailability and tolerance, with few adverse reactions. It is a β-1, 3-glucan synthase inhibitor with a new structure and has a good prospect in the clinical treatment of invasive fungal infections. This article reviewed the research and development process, clinical research and drug interactions of ibrexafungerp.

ibrexafungerp  /  enfumafungin  /  vulvovaginal candidiasis
汪君怡, 陈浩东, 汤佳伟, 杨松柏, 陈少欣. 抗真菌药物艾瑞芬净的临床研究进展. 世界临床药物, 2025 , 46 (9) : 972 -977 . DOI: 10.13683/j.wph.2025.09.016
Junyi WANG, Haodong CHEN, Jiawei TANG, Songbai YANG, Shaoxin CHEN. Clinical research progress of the antifungal drug ibrexafungerp[J]. World Clinical Drug, 2025 , 46 (9) : 972 -977 . DOI: 10.13683/j.wph.2025.09.016
Year 2025 volume 46 Issue 9
50
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.09.016
  • Receive Date:2025-01-07
  • Online Date:2026-11-09
  • Published:2025-09-10
Article Data
Affiliations
History
  • Received:2025-01-07
Funding
Affiliations
    China state Institute of Pharmaceutical Industry, Shanghai Institute of Pharmaceutical Industry, National Key Laboratory of Lead Druggability Research, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.09.016
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT